PRESENTATION
Why a course of Market Access?
Market Access is a complex process. It is the fourth hurdle in drug development and is today an inescapable reality. It has become the driver of the global income of a new product/drug. No company providing drugs or devices can expect to succeed without designing a pricing and reimbursement strategy early in the development process.
The concept of Market Access requires as much knowledge as professional capabilities. It is situated at a crossroads of multiple disciplines that all form an integral part of a valid comprehensive course.
The course, exclusively taught in English, is the very first European degree in the field of Market Access. Speakers and contributors come from institutional organizations, the academic world and the healthcare industry. Their presentations will cover Market Access Policies, Pricing in Europe and outside Europe, Health Economics, Health Technology Assessment (HTA) and Risk Management and Decision Sciences.
What is the objective of the course?
- Get an advanced understanding of the Market Access environment and principles
- Focus on the latest regulations and guidelines in Europe and outside Europe
- Draw a mapping of new actors : how they become inescapable decision makers
- Give techniques and tools to implement in their business
- Develop knowledge in decision sciences
- Allow contacts with experts from different organizations, public or private, who are main actors in the health industry and who deal with the issues everyday
- Deliver the best practices of leading companies
Key Learning
- Set up a successful pricing and market strategy
- Develop, validate and execute a market access plan
- Build value story to optimize market access
- Understand strengths and pitfalls of available evidence
- Design a pricing research
- Define a pricing strategy
- Anticipate the future paradigm changes in market access
Who should attend?
EMAUD is intended for students and professionals in the fields of life science and healthcare industries.
Contributors
European HTA and Pricing agencies, Non-Governmental agencies, Industry representatives and Academics.
Testimonials
Available soon the very first feedback from participants
|
